Opportunities for Pan-Spectrum Drugs against Herpes
Predicting the Unpredictable
GPCR FlAsH-Walk Mapping: A Leap into the Future
A promising projects portfolio
As of today, CQDM has 34 outstanding research projects for a total of $ 31.8 M invested. These projects are carried out by a network of more than 450 researchers, including close to 85 graduate students, from 50 research institutions (28 public and 22 private) in Quebec, Canada and internationally. These projects cut across about 80 mentors from CQDM’s pharmaceutical companies members.